Filing Details

Accession Number:
0001144204-13-049410
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-05 16:31:16
Reporting Period:
2013-09-03
Filing Date:
2013-09-05
Accepted Time:
2013-09-05 16:31:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235007 Endocyte Inc ECYT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1509418 Ron P Ellis 3000 Kent Ave Ste A1-100
West Lafayette IN 47906
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-09-03 3,000 $14.54 26,154 No 4 S Direct
Common Stock Acquisiton 2013-09-04 3,000 $1.91 29,154 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock option (right to buy) Disposition 2013-09-04 3,000 $0.00 3,000 $1.91
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,089 2015-02-10 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 75,332 Direct
Footnotes
  1. The shares were sold pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.
  2. The reported securities are owned directly by P. Ron Ellis and Margaret Heard Ellis, JTWROS.
  3. The option is fully vested and immediately exercisable.